HOMER2P2

Across TCGA pan-cancer cohorts, HOMER2P2 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of HOMER2P2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where HOMER2P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HOMER2P2 is over-expressed in tumor, although a few such as STAD and COAD show the opposite, repressed pattern.

KIRC, BRCA, and HNSC are the cancer types where HOMER2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HOMER2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.053	<.001	7	view →
BRCA	Female	All	+0.054	<.001	4	view →
HNSC	All	All	+0.025	.016	3	view →
STAD	Male	IV	−0.225	<.001	2	view →
COAD	All	II,III,IV	−0.012	.021	2	view →
THCA	Female	All	−0.015	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

HOMER2P2–KIRC

Open the KIRC breakdown →